Introduction: The Gateway from Laboratory to Life-Saving Medicine Imagine a promising new drug candidate developed in a state-of-the-art pharmaceutical research facility. Backed by years of preclinical studies and bursting with therapeutic potential,...
When COVID‑19 hit, clinical trials faced a trifecta of obstacles: halted site operations, disrupted participant recruitment, and compromised data integrity. With hospitals busy managing pandemic care, many trial sites closed or shifted priorities, de...
The COVID‑19 pandemic brought clinical trials to a grinding halt, forcing researchers and pharmaceutical sponsors to rethink the traditional trial model. Suddenly, participant recruitment and retention became daunting tasks as social distancing and l...
In recent years, precision medicine has evolved from a concept into a clinical reality. This shift focuses on personalized treatments based on a patient's unique genetic, environmental, and lifestyle profile. Precision medicine is revolutionizing dru...